Skip to main content
Clinical Trials/NCT03760380
NCT03760380
Withdrawn
N/A

Pilot Study: Comparing Pain and Kinematic Outcomes of Two Gait-Modifying Shoe Interventions on Knee Osteoarthritis Acutely and Over a 12 Week Period

University of Florida0 sitesApril 16, 2019
ConditionsArthritis Knee

Overview

Phase
N/A
Intervention
Not specified
Conditions
Arthritis Knee
Sponsor
University of Florida
Primary Endpoint
Change in NRS pain (Pain Numeric Rating Scale) score.
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

This study involves the use of a newly designed shoe device for knee arthritis patients that may help reduce knee pain and improve function.

Detailed Description

This study involves the use of a newly designed shoe device for knee arthritis patients that may help reduce knee pain and improve function. This is a 2-phase study designed to evaluate knee pain and function in healthy participants with a history of medial knee arthritis. The purpose of this study is to evaluate: 1. how using the shoe device will affect a person's walking gait and balance over a single day; and 2. how using the shoe device over the course of a 12-week period will affect a person's walking gait and balance.

Registry
clinicaltrials.gov
Start Date
April 16, 2019
End Date
November 10, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Chronic, OA-related knee pain
  • Diagnosis of medial compartment knee OA (unilateral or bilateral)
  • Moderate pain of ≥4 out of 10 points while performing a weight-bearing activity
  • Kellgren and Lawrence score of 2, 3, or 4 evidenced on routine, standard-of-care x-ray within the last 2 years prior to enrollment
  • Able to walk unassisted for at least 10 minutes at a time
  • Wear a Women's shoe size of 6.5 to 13 or a Men's shoe size of 5 to 12.

Exclusion Criteria

  • Patients suffering from acute septic or inflammatory arthritis
  • Unstable cardiovascular, orthopaedic, or neurological conditions, uncontrolled diabetes, or any condition that would preclude exercise in moderate duration, moderate workload trials
  • Received a corticosteroid injection or invasive procedures within prior 6 months of the study
  • History of avascular necrosis in the knee
  • History of knee buckling
  • Joint replacement in any lower extremity joint that has not optimally recovered (e.g. still causes significant pain or affects mobility) as determined by the PI.
  • Experienced more than 3 falls within the last year
  • Currently using any knee brace on a regular basis for the knee pain, with the exception of basic knee sleeves
  • Pathological osteoporotic fracture
  • Severe symptomatic degenerative arthritis in lower limb joints other than the knees

Outcomes

Primary Outcomes

Change in NRS pain (Pain Numeric Rating Scale) score.

Time Frame: Baseline (Phase 1); Baseline (Phase 2), Week 4, Week 8, Week 12

Participants selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as one can imagine" or "worst pain imaginable").

Secondary Outcomes

  • Change in SF-36 disability score.(Baseline (Phase 2), Week 4, Week 8, Week 12)
  • Change in WOMAC (Western Ontario and McMaster Universities Arthritis Index) score(Baseline (Phase 2), Week 4, Week 8, Week 12)
  • Change in Stair Climb time score.(Baseline (Phase 2), Week 4, Week 8, Week 12)
  • Change in Timed Up & Go (TUG) Test score.(Baseline (Phase 2), Week 4, Week 8, Week 12)

Similar Trials